Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
29.00
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.031B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 21.21% |
| Valuation | |
| PE Ratio | 15.81 |
| PE Ratio (Forward) | |
| PS Ratio | 1.97 |
| Price to Book Value | 1.179 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.4087 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0088 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 70.24% |
Profile
| Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan. |
| URL | http://www.hisamitsu.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Saga |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 09, 2026 (est.) |
| Last Earnings Release | Jan. 08, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 29, 2025 |
Profile
| Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan. |
| URL | http://www.hisamitsu.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Saga |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 09, 2026 (est.) |
| Last Earnings Release | Jan. 08, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 29, 2025 |